We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

69 hedge funds and large institutions have $542M invested in Portola Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

14% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 22

12% more capital invested

Capital invested by funds: $485M → $542M (+$56.5M)

11% more funds holding

Funds holding: 62 → 69 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
69
Holders Change
+7
Holders Change %
+11.29%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
12
Increased
25
Reduced
22
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
+$16.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.16M
4
Norges Bank
Norges Bank
Norway
+$2.2M
5
Northern Trust
Northern Trust
Illinois
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$9.71M
2
BI
BVF Inc
California
-$7.51M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$3.98M
4
O
OrbiMed
New York
-$3.65M
5
ICAP
Independence Capital Asset Partners
Colorado
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$3.29M +$620K +26,043 +27%
DM
27
Deerfield Management
New York
$3.19M -$9.71M -407,962 -77%
Norges Bank
28
Norges Bank
Norway
$2.47M +$2.2M +92,358 New
Wells Fargo
29
Wells Fargo
California
$2.19M -$265K -11,121 -12%
Morgan Stanley
30
Morgan Stanley
New York
$1.76M -$400K -16,792 -20%
PAMU
31
Pictet Asset Management (UK)
United Kingdom
$1.25M +$311K +13,050 +39%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$1.21M +$630K +26,458 +141%
TCIM
33
TIAA CREF Investment Management
New York
$1.19M +$127K +5,348 +14%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.12M -$130K -5,449 -11%
TC
35
TFS Capital
Pennsylvania
$884K +$570K +23,943 +264%
BA
36
BlackRock Advisors
Delaware
$816K +$615K +25,852 +558%
CCMH
37
Cornerstone Capital Management Holdings
New York
$741K +$659K +27,700 New
BIM
38
BlackRock Investment Management
Delaware
$736K +$55.7K +2,340 +9%
Deutsche Bank
39
Deutsche Bank
Germany
$693K +$183K +7,695 +42%
AllianceBernstein
40
AllianceBernstein
Tennessee
$581K +$250K +10,490 +93%
Charles Schwab
41
Charles Schwab
California
$550K +$20.8K +873 +5%
AQR Capital Management
42
AQR Capital Management
Connecticut
$522K +$464K +19,500 New
TD Asset Management
43
TD Asset Management
Ontario, Canada
$476K +$424K +17,800 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$462K +$9.52K +400 +2%
Jane Street
45
Jane Street
New York
$434K +$53.2K +2,234 +16%
TA
46
Teachers Advisors
New York
$370K +$25K +1,051 +8%
MLICM
47
Metropolitan Life Insurance Company (MetLife)
New York
$283K -$8.8K -370 -3%
RFC
48
Russell Frank Company
Washington
$241K +$1.24K +52 +0.6%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$239K -$97.9K -4,114 -32%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$226K -$214 -9 -0.1%
1
2
3

PTLA Hedge Fund Activity: Q3 2013 in Review

69 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2013, worth a combined $542M — up 12% from $485M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PTLA positions and 5 closed out — a net gain of 7 holders — while 25 added to existing stakes and 22 trimmed.

The largest buyer was Ontario Teachers' Pension Plan Board, adding an estimated $16.1M. The largest seller was Deerfield Management, cutting an estimated $9.71M.

  • 69 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2013, up from 62 in Q2 2013.
  • Funds reported $542M of Portola Pharmaceuticals, Inc. stock for Q3 2013, up 12% quarter-over-quarter.
  • 12 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2013 and 5 closed out, a net change of +7 holders.
  • The largest Portola Pharmaceuticals, Inc. buyer in Q3 2013 was Ontario Teachers' Pension Plan Board, an estimated $16.1M added.
  • The largest Portola Pharmaceuticals, Inc. seller in Q3 2013 was Deerfield Management, an estimated $9.71M sold.

Based on aggregated 13F filings for Q3 2013.